Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium

Grants

Funding Acknowledgements

Grant sponsor: Cancer Research UK; Grant number: C1287/A16563, C1287/A10118, C1287/A10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565; Grant sponsor: European Union's Horizon 2020 Research and Innovation Programme; Grant number: 634935, 633784; Grant sponsor: European Community's Seventh Framework Programme; Grant number: 223175 (HEALTHF2-2009-223175); Grant sponsor: National Institutes of Health; Grant number: CA128978; Grant sponsor: Post-Cancer GWAS initiative; Grant number: 1U19 CA148537, 1U19 CA148065, 1U19 CA148112; Grant sponsor: Department of Defence; Grant number: W81XWH-10-1-0341; Grant sponsor: Canadian Institutes of Health Research (CIHR); Grant number: CRN-87521; Grant sponsor: Komen Foundation for the Cure; Grant sponsor: Breast Cancer Research Foundation; Grant sponsor: Ovarian Cancer Research Fund; Grant sponsor United States National Cancer Institute, National Institutes of Health (NIH); Grant number: RFA-CA-06-503; Grant sponsor: Breast Cancer Family Registry (BCFR), Cancer Care Ontario; Grant number: U01 CA69467; Grant sponsor: Cancer Prevention Institute of California; Grant number: U01 CA69417; Grant sponsor: University of Melbourne; Grant number: U01 CA69638; Grant sponsor: National Cancer Institute; Grant number: UM1 CA164920; Grant sponsor: National Health and Medical Research Council of Australia; Grant sponsor: New South Wales Cancer Council; Grant sponsor: Victorian Health Promotion Foundation; Grant sponsor: Victorian Breast Cancer Research Consortium; Grant sponsor: Dutch Cancer Society; Grant number: NKI 2007-3839; 2009-4363; Grant sponsor: Dutch Government; Grant number: NWO 184.021.007; Grant sponsor: Dutch National Genomics Initiative; Grant sponsor: ELAN-Fond; Grant sponsor: Accion Estrategica de Salud del Institute de Salud Carlos III; Grant number: FIS PI12/02125, PI13/01136; Grant sponsor: KAU; Grant number: 1-117-1434-HiCi; Grant sponsor: Botin Foundation's Fund; Grant sponsor: Programa Grupos Emergentes, Cancer Genetics Unit, CHUVI Vigo Hospital, Institute de Investigacion Sanitaria Galicia Sur (IISGS), Institute de Salud Carlos III, Spain; Grant sponsor: Conselleria de Industria Programa Sectorial de Investigacion Aplicada, PEME vertical bar DEI vertical bar Suma del Plan Gallego de Investigacion, Desarrollo c Innovation Tecnologica de la Conselleria de Industria de la Xunta de Galicia, Spain; Grant number: 10CSA012E; Grant sponsor: Fomento de la Investigation Clinica Indcpendiente, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain; Grant number: EC11-192; Grant sponsor: Grant FEDER-Innterconecta, Ministerio de Economia y Competitividad, Xunta de Galicia, Spain; Grant sponsor: Fondation de France; Grant sponsor: Institut National du Cancer (INCa); Grant sponsor: Ligue Nationale contre le Cancer; Grant sponsor: Ligue contre le Cancer Grand Ouest; Grant sponsor: Agence Nationale de Securite Sanitaire (ANSES); Grant sponsor: Agent Nationale de la Recherche (ANR); Grant sponsor: Chief Physician Johan Boserup and Lise Boserup Fund; Grant sponsor: Danish Medical Research Council; Grant sponsor: Herlev Hospital; Grant sponsor: American Cancer Society; Grant sponsor: Baden Wurttemberg Ministry of Science, Research and Arts; Grant sponsor: German Cancer Aid (Deutsche Krcbshilfe); Grant sponsor: Federal Ministry of Education and Research (BMBF), Germany; Grant number: 01KW9975/5, 01KW9976/8, 01KW9977/0, 01KW0114; Grant sponsor: Robert Bosch Foundation, Stuttgart; Grant sponsor: Deutsches Krebsforschungszentrum (DKFZ), Heidelberg; Grant sponsor: Institute for Prevention and Occupational Medicine of the German Social Accident Insurance; Grant sponsor: Institute of the Ruhr University Bochum (IPA), Bochum; Grant sponsor: Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany; Grant sponsor: Government Funding (EVO) of Kuopio University Hospital; Grant sponsor: Cancer Fund of North Savo; Grant sponsor: Finnish Cancer Organizations; Grant sponsor: University of Eastern Finland; Grant sponsor: Stichting tegen Kanker; Grant number: 232-2008, 196-2010; Grant sponsor: FWO; Grant number: KULPFV/10/016-SymBioSysII; Grant sponsor: KULPFV; Grant number: 70-2892-BR I, 106332, 108253, 108419, 110826, 110828; Grant sponsor: Hamburg Cancer Society; Grant sponsor: NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer; Grant number: CA116201; Grant sponsor: David F. and Margaret T.; Grant sponsor: Grohnc Family Foundation; Grant sponsor: VicHealth; Grant sponsor: Cancer Council Victoria; Grant sponsor: NHMRC; Grant number: 209057, 251553, 504711; Grant sponsor: Quebec Breast Cancer Foundation; Grant sponsor: CIHR Team in Familial Risks of Breast Cancer; Grant sponsor: Ministry of Economic Development, Innovation and Export Trade; Grant number: # PSR-S11R1-701; Grant sponsor: Intramural Research Funds, National Cancer Institute, Department of Health and Human Services, USA; Grant sponsor: Marit and Hans Rausings Initiative Against Breast Cancer; Grant sponsor: Cancer Risk Prediction Center CRisP; Grant sponsor: Linnaeus Centre; Grant sponsor: Swedish Research Council; Grant number: 70867902; Grant sponsor: Agency for Science, Technology and Research of Singapore (A*STAR); Grant sponsor US National Institute of Health (NIH); Grant sponsor: Susan G. Komen Breast Cancer Foundation; Grant sponsor: Yorkshire Cancer Research; Grant number: S295, S299, S305PA; Grant sponsor: Sheffield Experimental Cancer Medicine Centre; Grant sponsor: UK National Institute for Health Research Biomedical Research Centre, University of Cambridge; Grant sponsor: Cancer Research UK; Grant sponsor: Breast Cancer Now; Grant sponsor: Institute of Cancer Research (ICR), London; Grant sponsor: Cancer Care Ontario; Grant number: U01 CA69467; Grant sponsor: National Cancer Institute; Grant number: UM1 CA164920; Grant sponsor: Accion Estrategica de Salud del Instituto de Salud Carlos III; Grant number: EIS PI12/02125, PI13/01136